Lineage Cell Therapeutics (LCTX) Total Debt Growth (1y) (2015 - 2017)
Lineage Cell Therapeutics (LCTX) Total Debt Growth (1y) (2015 - 2017) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 103.99% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 3.84% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Lineage Cell Therapeutics | 251.15 Mn | 188.44 Mn | 1.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -85.00% |
| Sep 30, 2017 | -74.57% |
| Jun 30, 2017 | -45.09% |
| Mar 31, 2017 | -56.82% |
| Dec 31, 2016 | -51.22% |
| Sep 30, 2016 | -35.45% |
| Jun 30, 2016 | 5,666.67% |
| Mar 31, 2016 | 1,171.16% |
| Dec 31, 2015 | 693.55% |
| Sep 30, 2015 | 496.05% |
| Jun 30, 2015 | -94.78% |